BILL ANALYSIS H.B. 2022 By: Berlanga (Zaffirini) Finance 5-18-95 Senate Committee Report (Unamended) BACKGROUND The Texas Department of Health (department) operates the largest public health laboratory in the country. Services provided include screening tests for specific diseases in newborn infants, tuberculosis, sexually transmitted diseases, rabies, childhood blood lead poisoning, as well as microbiology services and various environmental health testing services. The laboratory plays a key role in testing public drinking water supplies, as mandated by the federal Safe Drinking Water Act. The department's current space is not sufficient to meet its staffing and technological needs. The physical structure no longer has adequate air flow capacity for additional air management systems. This causes a serious problem in that the air handling system for the tuberculosis isolation laboratory is shared with the rest of the main laboratory. These issues related to space, engineering, and safety severely limit the laboratory's ability to respond to current and future analytical needs. PURPOSE As proposed, H.B. 2022 authorizes the issuance of revenue bonds for construction of a laboratory and office facility for the Texas Department of Health. RULEMAKING AUTHORITY It is the committee's opinion that this bill does not grant any additional rulemaking authority to a state officer, institution, or agency. SECTION BY SECTION ANALYSIS SECTION 1. Amends Section 24A(b), Article 601d, V.T.C.S., (Texas Public Finance Authority Act), to include laboratory and office facilities for the Texas Department of Health, at an estimated cost of $42,300,000, among the projects that are approved, bringing the total cost for all projects to $170,933,000, rather than $128,633,000. SECTION 2. Emergency clause. Effective date: upon passage.